Altimmune (ALT) EBITDA (2010 - 2026)
Altimmune's EBITDA came in at -$26.21 million for Q2 2026, compared with -$22.89 million a year earlier.
Powered by 
Analysis
Altimmune (ALT) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Altimmune reported EBITDA of -$100.13 million; for FY2025, it was -$94.38 million.
- Going back by year, EBITDA was -$102.93 million in FY2024, -$95.43 million in FY2023, -$87.95 million in FY2022 and -$96.36 million in FY2021.
- The five-year range for quarterly EBITDA is -$33.49 million (Q4 2023) to -$18.51 million (Q2 2023).
- Business Quant data shows ALT's EBITDA at -$24.22 million (Q1 2026), -$28.87 million (Q4 2025) and -$20.83 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Altimmune | 575.64 Mn | 575.64 Mn | - | -26.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.21 Mn |
| Mar 31, 2026 | -24.22 Mn |
| Dec 31, 2025 | -28.87 Mn |
| Sep 30, 2025 | -20.83 Mn |
| Jun 30, 2025 | -22.89 Mn |
| Mar 31, 2025 | -21.79 Mn |
| Dec 31, 2024 | -24.83 Mn |
| Sep 30, 2024 | -24.73 Mn |
| Jun 30, 2024 | -26.68 Mn |
| Mar 31, 2024 | -26.69 Mn |
| Dec 31, 2023 | -33.49 Mn |
| Sep 30, 2023 | -23.09 Mn |
| Jun 30, 2023 | -18.51 Mn |
| Mar 31, 2023 | -22.12 Mn |
| Dec 31, 2022 | -23.33 Mn |
| Sep 30, 2022 | -24.89 Mn |
| Jun 30, 2022 | -20.34 Mn |
| Mar 31, 2022 | -19.38 Mn |
| Dec 31, 2021 | -23.87 Mn |
| Sep 30, 2021 | -32.92 Mn |
API Access
Altimmune EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();